malondialdehyde has been researched along with Scleroderma, Localized in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, T; Xu, SH; Yu, JF; Yu, QY; Zhang, JX; Zhou, CF; Zhu, QX | 1 |
| Albrecht-Nebe, H; Eggert, W; Grune, T; Michel, P | 1 |
2 other study(ies) available for malondialdehyde and Scleroderma, Localized
| Article | Year |
|---|---|
N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Bleomycin; Catalase; Disease Models, Animal; Female; Fibrosis; Free Radical Scavengers; Injections, Subcutaneous; Malondialdehyde; Mice; Mice, Inbred BALB C; Oxidative Stress; Reactive Oxygen Species; Scleroderma, Localized; Skin; Superoxide Dismutase; Thiobarbiturates | 2013 |
Increased lipid peroxidation in children with autoimmune diseases.
Topics: Adolescent; Adult; Aldehydes; Autoimmunity; Child; Female; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Scleroderma, Localized | 1997 |